Pasithea Therapeutics Corp. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for KTTA, updated each market day.
KTTA AI Sentiment
AI predicts Pasithea Therapeutics Corp. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Pasithea Therapeutics Corp. Common Stock
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
Sector
Exchange
Market Cap
$17,956,762
Cap Tier
Employees
5
Headquarters
MIAMI BEACH, FL
Listed Since
Sept. 15, 2021
Website
KTTA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KTTA Volatility
Pasithea Therapeutics Corp. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
